APA

Haga K., Lemp N. A., Logg C. R., Nagashima J., Faure-Kumar E., Gomez G. G., Kruse C. A., Mendez R., Stripecke R., Kasahara N., Kasahara N. A. & Cicciarelli J. C. (20070430). Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes. : Transplantation proceedings.

Chicago

Haga K, Lemp N A, Logg C R, Nagashima J, Faure-Kumar E, Gomez G G, Kruse C A, Mendez R, Stripecke R, Kasahara N, Kasahara N A and Cicciarelli J C. 20070430. Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes. : Transplantation proceedings.

Harvard

Haga K., Lemp N. A., Logg C. R., Nagashima J., Faure-Kumar E., Gomez G. G., Kruse C. A., Mendez R., Stripecke R., Kasahara N., Kasahara N. A. and Cicciarelli J. C. (20070430). Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes. : Transplantation proceedings.

MLA

Haga K, Lemp N A, Logg C R, Nagashima J, Faure-Kumar E, Gomez G G, Kruse C A, Mendez R, Stripecke R, Kasahara N, Kasahara N A and Cicciarelli J C. Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs: Averting cytotoxicity by alloreactive T lymphocytes. : Transplantation proceedings. 20070430.